191 related articles for article (PubMed ID: 26030049)
1. Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation.
von Bahr L; Blennow O; Alm J; Björklund A; Malmberg KJ; Mougiakakos D; Le Blanc A; Oefner PJ; Labopin M; Ljungman P; Le Blanc K
Bone Marrow Transplant; 2015 Sep; 50(9):1217-23. PubMed ID: 26030049
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
3. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
4. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
[TBL] [Abstract][Full Text] [Related]
5. Vitamin d levels affect outcome in pediatric hematopoietic stem cell transplantation.
Hansson ME; Norlin AC; Omazic B; Wikström AC; Bergman P; Winiarski J; Remberger M; Sundin M
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1537-43. PubMed ID: 24910378
[TBL] [Abstract][Full Text] [Related]
6. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus Infection and Treatment in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from a Single Institution in an Endemic Area.
Lin HC; Han SM; Hwang WL; Chou CW; Chang KH; Shi ZY; Jerry Teng CL
Turk J Haematol; 2017 Jun; 34(2):159-166. PubMed ID: 27610628
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
He J; Chen BA; Ni M; Wu X; Ding JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1371-6. PubMed ID: 25338591
[TBL] [Abstract][Full Text] [Related]
10. Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD.
Glotzbecker B; Ho VT; Aldridge J; Kim HT; Horowitz G; Ritz J; Soiffer R; Avigan D; Rosenblatt J
Bone Marrow Transplant; 2013 Apr; 48(4):593-7. PubMed ID: 23000654
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease.
Ljubas Kelecic D; Lelas A; Karas I; Desnica L; Vukic T; Sabol I; Vranesic Bender D; Serventi Seiwerth R; Peric Z; Durakovic N; Vitali Cepo D; Vrhovac R; Nemet D; Pavletic S; Pulanic D; Krznaric Z
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2967-2978. PubMed ID: 32507973
[TBL] [Abstract][Full Text] [Related]
13. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D deficiency and outcomes in pediatric hematopoietic stem cell transplantation.
Beebe K; Magee K; McNulty A; Stahlecker J; Salzberg D; Miller H; Mirea L; Adams R; Ngwube A
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28960811
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
Yanada M; Yamamoto K; Emi N; Naoe T; Suzuki R; Taji H; Iida H; Shimokawa T; Kohno A; Mizuta S; Maruyama F; Wakita A; Kitaori K; Yano K; Hamaguchi M; Hamajima N; Morishima Y; Kodera Y; Sao H; Morishita Y
Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant.
Wallace G; Jodele S; Howell J; Myers KC; Teusink A; Zhao X; Setchell K; Holtzapfel C; Lane A; Taggart C; Laskin BL; Davies SM
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1627-31. PubMed ID: 26093045
[TBL] [Abstract][Full Text] [Related]
17. [Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation].
Liu QF; Sun J; Zhang Y; Xu D; Liu XL; Xu B; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1143-5. PubMed ID: 14625172
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of risk factors for secondary cytopenia after allogeneic hematopoietic stem cell transplantation].
Lin Z; Kong Y; Wang Y; Zhang X; Liu D; Xu L; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):4-8. PubMed ID: 24602722
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency is not associated with graft versus host disease after hematopoietic stem cell transplantation: A meta-analysis.
Chiengthong K; Cheungpasitporn W; Thongprayoon C; Lertjitbanjong P; Cato LD; Bathini T; Ungprasert P; Mao MA; Chokesuwattanaskul R
J Evid Based Med; 2020 Aug; 13(3):183-191. PubMed ID: 32369679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
